Regarding customized patient medication packages, which statement is true about returns?

• A. They can be re-dispensed to stock after patient possession
• B. They are eligible for full refunds if unopened
• C. They must be destroyed after the patient possession
• D. They cannot be re-dispensed or returned to stock if the patient has taken possession of them

Answer: (D)

When medications are put into customized patient medication packages, the key idea is maintaining safety and proper tracking for that specific patient. Once the patient has possession of a customized package, the product’s integrity for use by someone else can’t be guaranteed. This is why re-dispensing to stock isn’t allowable—the package may have been altered, labeled, or dosed for a particular patient, and handling it as if it were standard stock would risk errors, tampering concerns, and regulatory issues. Because of these safety and accountability factors, refunds for an unopened status aren’t appropriate either, since the item has already been prepared for a specific patient and is no longer a generic stock item. The correct course is to destroy or dispose of the package in accordance with policy, ensuring it’s not reused or inadvertently given to another patient.